Atlas Trials

c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

Clinical trial NCT04833036 · UNKNOWN

Trial details

NCT number
NCT04833036
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2019-10-01
Primary completion
2022-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.